 | • レポートコード：GIR201115807 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、肝疾患治療の世界市場を調査対象にし、肝疾患治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（化学療法薬、標的療法、抗ウイルス薬、免疫グロブリン、コルチコステロイド、ワクチン、抗拒絶薬/免疫抑制剤）、用途別分析（がん、肝炎、肝硬変、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Abbott Laboratories、Sanofi-Aventis、Merck、Bayer Schering、Roche、Eli Lilly、Zydus Pharmaceuticals、Pfizer、Novartis、Takeda Pharmaceutical、Siemens、Elekta、Glaxosmithkline、Samsung Healthcare、Canon Medical Systems Corp、Koninklijke Philips、Bristol-Myers Squibb、Neusoft Corporation、Hitachi、General Electric、Verva Pharmaceuticals、BPL Medical Technologies、LG Life Sciences、Gilead Sciences、Raptor Pharmaceuticals、Achillion Pharmaceuticals、ProMetic Life Sciences、Cura Healthcare、Shenzhen Kangtai Biological Products、Angion Biomedica、Phenex Pharmaceuticals ・企業別売上、市場シェア ・肝疾患治療の地域別市場分析 ・肝疾患治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・肝疾患治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・肝疾患治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・肝疾患治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・肝疾患治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・肝疾患治療の種類別市場規模2015-2020：化学療法薬、標的療法、抗ウイルス薬、免疫グロブリン、コルチコステロイド、ワクチン、抗拒絶薬/免疫抑制剤 ・肝疾患治療の用途別市場規模2015-2020：がん、肝炎、肝硬変、その他 ・肝疾患治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Liver Diseases Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Liver Diseases Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Liver Diseases Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Liver Diseases Treatment market has been segmented into:
Chemotherapy Drugs
Targeted Therapy
Anti-Viral Drugs
Immunoglobulins
Corticosteroids
Vaccines
Anti-Rejection Drugs/Immunosuppressant
By Application, Liver Diseases Treatment has been segmented into:
Cancer
Hepatitis
Cirrhosis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Liver Diseases Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Liver Diseases Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Liver Diseases Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Liver Diseases Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Liver Diseases Treatment Market Share Analysis
Liver Diseases Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Liver Diseases Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Liver Diseases Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Liver Diseases Treatment are:
Abbott Laboratories
Sanofi-Aventis
Merck
Bayer Schering
Roche
Eli Lilly
Zydus Pharmaceuticals
Pfizer
Novartis
Takeda Pharmaceutical
Siemens
Elekta
Glaxosmithkline
Samsung Healthcare
Canon Medical Systems Corp
Koninklijke Philips
Bristol-Myers Squibb
Neusoft Corporation
Hitachi
General Electric
Verva Pharmaceuticals
BPL Medical Technologies
LG Life Sciences
Gilead Sciences
Raptor Pharmaceuticals
Achillion Pharmaceuticals
ProMetic Life Sciences
Cura Healthcare
Shenzhen Kangtai Biological Products
Angion Biomedica
Phenex Pharmaceuticals
Table of Contents
1 Liver Diseases Treatment Market Overview
1.1 Product Overview and Scope of Liver Diseases Treatment
1.2 Classification of Liver Diseases Treatment by Type
1.2.1 Global Liver Diseases Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Liver Diseases Treatment Revenue Market Share by Type in 2019
1.2.3 Chemotherapy Drugs
1.2.4 Targeted Therapy
1.2.5 Anti-Viral Drugs
1.2.6 Immunoglobulins
1.2.7 Corticosteroids
1.2.8 Vaccines
1.2.9 Anti-Rejection Drugs/Immunosuppressant
1.3 Global Liver Diseases Treatment Market by Application
1.3.1 Overview: Global Liver Diseases Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Hepatitis
1.3.4 Cirrhosis
1.3.5 Other
1.4 Global Liver Diseases Treatment Market by Regions
1.4.1 Global Liver Diseases Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Liver Diseases Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Liver Diseases Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Liver Diseases Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Liver Diseases Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Liver Diseases Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Liver Diseases Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi-Aventis
2.2.1 Sanofi-Aventis Details
2.2.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi-Aventis SWOT Analysis
2.2.4 Sanofi-Aventis Product and Services
2.2.5 Sanofi-Aventis Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer Schering
2.4.1 Bayer Schering Details
2.4.2 Bayer Schering Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer Schering SWOT Analysis
2.4.4 Bayer Schering Product and Services
2.4.5 Bayer Schering Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly
2.6.1 Eli Lilly Details
2.6.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly SWOT Analysis
2.6.4 Eli Lilly Product and Services
2.6.5 Eli Lilly Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Zydus Pharmaceuticals
2.7.1 Zydus Pharmaceuticals Details
2.7.2 Zydus Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Zydus Pharmaceuticals SWOT Analysis
2.7.4 Zydus Pharmaceuticals Product and Services
2.7.5 Zydus Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Novartis SWOT Analysis
2.9.4 Novartis Product and Services
2.9.5 Novartis Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda Pharmaceutical
2.10.1 Takeda Pharmaceutical Details
2.10.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda Pharmaceutical SWOT Analysis
2.10.4 Takeda Pharmaceutical Product and Services
2.10.5 Takeda Pharmaceutical Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Siemens
2.11.1 Siemens Details
2.11.2 Siemens Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Siemens SWOT Analysis
2.11.4 Siemens Product and Services
2.11.5 Siemens Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Elekta
2.12.1 Elekta Details
2.12.2 Elekta Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Elekta SWOT Analysis
2.12.4 Elekta Product and Services
2.12.5 Elekta Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Glaxosmithkline
2.13.1 Glaxosmithkline Details
2.13.2 Glaxosmithkline Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Glaxosmithkline SWOT Analysis
2.13.4 Glaxosmithkline Product and Services
2.13.5 Glaxosmithkline Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Samsung Healthcare
2.14.1 Samsung Healthcare Details
2.14.2 Samsung Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Samsung Healthcare SWOT Analysis
2.14.4 Samsung Healthcare Product and Services
2.14.5 Samsung Healthcare Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Canon Medical Systems Corp
2.15.1 Canon Medical Systems Corp Details
2.15.2 Canon Medical Systems Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Canon Medical Systems Corp SWOT Analysis
2.15.4 Canon Medical Systems Corp Product and Services
2.15.5 Canon Medical Systems Corp Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 Koninklijke Philips
2.16.1 Koninklijke Philips Details
2.16.2 Koninklijke Philips Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Koninklijke Philips SWOT Analysis
2.16.4 Koninklijke Philips Product and Services
2.16.5 Koninklijke Philips Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Bristol-Myers Squibb
2.17.1 Bristol-Myers Squibb Details
2.17.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Bristol-Myers Squibb SWOT Analysis
2.17.4 Bristol-Myers Squibb Product and Services
2.17.5 Bristol-Myers Squibb Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 Neusoft Corporation
2.18.1 Neusoft Corporation Details
2.18.2 Neusoft Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Neusoft Corporation SWOT Analysis
2.18.4 Neusoft Corporation Product and Services
2.18.3 Neusoft Corporation Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.19 Hitachi
2.19.1 Hitachi Details
2.19.2 Hitachi Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Hitachi SWOT Analysis
2.19.4 Hitachi Product and Services
2.19.5 Hitachi Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.20 General Electric
2.20.1 General Electric Details
2.20.2 General Electric Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 General Electric SWOT Analysis
2.20.4 General Electric Product and Services
2.20.5 General Electric Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.21 Verva Pharmaceuticals
2.21.1 Verva Pharmaceuticals Details
2.21.2 Verva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Verva Pharmaceuticals SWOT Analysis
2.21.4 Verva Pharmaceuticals Product and Services
2.21.5 Verva Pharmaceuticals Liver Diseases Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.22 BPL Medical Technologies
2.23 LG Life Sciences
2.24 Gilead Sciences
2.25 Raptor Pharmaceuticals
2.26 Achillion Pharmaceuticals
2.27 ProMetic Life Sciences
2.28 Cura Healthcare
2.29 Shenzhen Kangtai Biological Products
2.30 Angion Biomedica
2.31 Phenex Pharmaceuticals
3 Market Competition, by Players
3.1 Global Liver Diseases Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Liver Diseases Treatment Players Market Share
3.2.2 Top 10 Liver Diseases Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Liver Diseases Treatment Revenue and Market Share by Regions
4.2 North America Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
5 North America Liver Diseases Treatment Revenue by Countries
5.1 North America Liver Diseases Treatment Revenue by Countries (2015-2020)
5.2 USA Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
6 Europe Liver Diseases Treatment Revenue by Countries
6.1 Europe Liver Diseases Treatment Revenue by Countries (2015-2020)
6.2 Germany Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
6.4 France Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Liver Diseases Treatment Revenue by Countries
7.1 Asia-Pacific Liver Diseases Treatment Revenue by Countries (2015-2020)
7.2 China Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
7.5 India Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
8 South America Liver Diseases Treatment Revenue by Countries
8.1 South America Liver Diseases Treatment Revenue by Countries (2015-2020)
8.2 Brazil Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Liver Diseases Treatment by Countries
9.1 Middle East & Africa Liver Diseases Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Liver Diseases Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Liver Diseases Treatment Market Forecast by Type (2019-2024)
10.3 Chemotherapy Drugs Revenue Growth Rate (2015-2025)
10.4 Targeted Therapy Revenue Growth Rate (2015-2025)
10.5 Anti-Viral Drugs Revenue Growth Rate (2015-2025)
10.6 Immunoglobulins Revenue Growth Rate (2015-2025)
10.7 Corticosteroids Revenue Growth Rate (2015-2025)
10.8 Vaccines Revenue Growth Rate (2015-2025)
10.9 Anti-Rejection Drugs/Immunosuppressant Revenue Growth Rate (2015-2025)
11 Global Liver Diseases Treatment Market Segment by Application
11.1 Global Liver Diseases Treatment Revenue Market Share by Application (2015-2020)
11.2 Liver Diseases Treatment Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Hepatitis Revenue Growth (2015-2020)
11.5 Cirrhosis Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Liver Diseases Treatment Market Size Forecast (2021-2025)
12.1 Global Liver Diseases Treatment Market Size Forecast (2021-2025)
12.2 Global Liver Diseases Treatment Market Forecast by Regions (2021-2025)
12.3 North America Liver Diseases Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Liver Diseases Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Liver Diseases Treatment Revenue Market Forecast (2021-2025)
12.6 South America Liver Diseases Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Liver Diseases Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Liver Diseases Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Liver Diseases Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Liver Diseases Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Liver Diseases Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Laboratories Corporate Information, Location and Competitors
Table 6. Abbott Laboratories Liver Diseases Treatment Major Business
Table 7. Abbott Laboratories Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Abbott Laboratories SWOT Analysis
Table 9. Abbott Laboratories Liver Diseases Treatment Product and Solutions
Table 10. Abbott Laboratories Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi-Aventis Corporate Information, Location and Competitors
Table 12. Sanofi-Aventis Liver Diseases Treatment Major Business
Table 13. Sanofi-Aventis Liver Diseases Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi-Aventis SWOT Analysis
Table 15. Sanofi-Aventis Liver Diseases Treatment Product and Solutions
Table 16. Sanofi-Aventis Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck Liver Diseases Treatment Major Business
Table 19. Merck Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck Liver Diseases Treatment Product and Solutions
Table 22. Merck Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer Schering Corporate Information, Location and Competitors
Table 24. Bayer Schering Liver Diseases Treatment Major Business
Table 25. Bayer Schering Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Bayer Schering SWOT Analysis
Table 27. Bayer Schering Liver Diseases Treatment Product and Solutions
Table 28. Bayer Schering Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Roche Corporate Information, Location and Competitors
Table 30. Roche Liver Diseases Treatment Major Business
Table 31. Roche Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Roche SWOT Analysis
Table 33. Roche Liver Diseases Treatment Product and Solutions
Table 34. Roche Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Eli Lilly Corporate Information, Location and Competitors
Table 36. Eli Lilly Liver Diseases Treatment Major Business
Table 37. Eli Lilly Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Eli Lilly SWOT Analysis
Table 39. Eli Lilly Liver Diseases Treatment Product and Solutions
Table 40. Eli Lilly Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Zydus Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Zydus Pharmaceuticals Liver Diseases Treatment Major Business
Table 43. Zydus Pharmaceuticals Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Zydus Pharmaceuticals SWOT Analysis
Table 45. Zydus Pharmaceuticals Liver Diseases Treatment Product and Solutions
Table 46. Zydus Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Pfizer Corporate Information, Location and Competitors
Table 48. Pfizer Liver Diseases Treatment Major Business
Table 49. Pfizer Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Pfizer SWOT Analysis
Table 51. Pfizer Liver Diseases Treatment Product and Solutions
Table 52. Pfizer Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Novartis Corporate Information, Location and Competitors
Table 54. Novartis Liver Diseases Treatment Major Business
Table 55. Novartis Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Novartis SWOT Analysis
Table 57. Novartis Liver Diseases Treatment Product and Solutions
Table 58. Novartis Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 60. Takeda Pharmaceutical Liver Diseases Treatment Major Business
Table 61. Takeda Pharmaceutical Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Takeda Pharmaceutical SWOT Analysis
Table 63. Takeda Pharmaceutical Liver Diseases Treatment Product and Solutions
Table 64. Takeda Pharmaceutical Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Siemens Corporate Information, Location and Competitors
Table 66. Siemens Liver Diseases Treatment Major Business
Table 67. Siemens Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Siemens SWOT Analysis
Table 69. Siemens Liver Diseases Treatment Product and Solutions
Table 70. Siemens Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Elekta Corporate Information, Location and Competitors
Table 72. Elekta Liver Diseases Treatment Major Business
Table 73. Elekta Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Elekta SWOT Analysis
Table 75. Elekta Liver Diseases Treatment Product and Solutions
Table 76. Elekta Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Glaxosmithkline Corporate Information, Location and Competitors
Table 78. Glaxosmithkline Liver Diseases Treatment Major Business
Table 79. Glaxosmithkline Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Glaxosmithkline SWOT Analysis
Table 81. Glaxosmithkline Liver Diseases Treatment Product and Solutions
Table 82. Glaxosmithkline Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Samsung Healthcare Corporate Information, Location and Competitors
Table 84. Samsung Healthcare Liver Diseases Treatment Major Business
Table 85. Samsung Healthcare Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Samsung Healthcare SWOT Analysis
Table 87. Samsung Healthcare Liver Diseases Treatment Product and Solutions
Table 88. Samsung Healthcare Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Canon Medical Systems Corp Corporate Information, Location and Competitors
Table 90. Canon Medical Systems Corp Liver Diseases Treatment Major Business
Table 91. Canon Medical Systems Corp Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Canon Medical Systems Corp SWOT Analysis
Table 93. Canon Medical Systems Corp Liver Diseases Treatment Product and Solutions
Table 94. Canon Medical Systems Corp Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Koninklijke Philips Corporate Information, Location and Competitors
Table 96. Koninklijke Philips Liver Diseases Treatment Major Business
Table 97. Koninklijke Philips Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 98. Koninklijke Philips SWOT Analysis
Table 99. Koninklijke Philips Liver Diseases Treatment Product and Solutions
Table 100. Koninklijke Philips Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 102. Bristol-Myers Squibb Liver Diseases Treatment Major Business
Table 103. Bristol-Myers Squibb Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 104. Bristol-Myers Squibb SWOT Analysis
Table 105. Bristol-Myers Squibb Liver Diseases Treatment Product and Solutions
Table 106. Bristol-Myers Squibb Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Neusoft Corporation Liver Diseases Treatment Type and Application
Table 108. Neusoft Corporation Liver Diseases Treatment Major Business
Table 109. Neusoft Corporation Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 110. Neusoft Corporation SWOT Analysis
Table 111. Neusoft Corporation Liver Diseases Treatment Product and Solutions
Table 112. Neusoft Corporation Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Hitachi Corporate Information, Location and Competitors
Table 114. Hitachi Liver Diseases Treatment Major Business
Table 115. Hitachi Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 116. Hitachi SWOT Analysis
Table 117. Hitachi Liver Diseases Treatment Product and Solutions
Table 118. Hitachi Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. General Electric Corporate Information, Location and Competitors
Table 120. General Electric Liver Diseases Treatment Major Business
Table 121. General Electric Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 122. General Electric SWOT Analysis
Table 123. General Electric Liver Diseases Treatment Product and Solutions
Table 124. General Electric Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Verva Pharmaceuticals Corporate Information, Location and Competitors
Table 126. Verva Pharmaceuticals Liver Diseases Treatment Major Business
Table 127. Verva Pharmaceuticals Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 128. Verva Pharmaceuticals SWOT Analysis
Table 129. Verva Pharmaceuticals Liver Diseases Treatment Product and Solutions
Table 130. Verva Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. BPL Medical Technologies Corporate Information, Location and Competitors
Table 132. BPL Medical Technologies Liver Diseases Treatment Major Business
Table 133. BPL Medical Technologies Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 134. BPL Medical Technologies SWOT Analysis
Table 135. BPL Medical Technologies Liver Diseases Treatment Product and Solutions
Table 136. BPL Medical Technologies Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. LG Life Sciences Corporate Information, Location and Competitors
Table 138. LG Life Sciences Liver Diseases Treatment Major Business
Table 139. LG Life Sciences Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 140. LG Life Sciences SWOT Analysis
Table 141. LG Life Sciences Liver Diseases Treatment Product and Solutions
Table 142. LG Life Sciences Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 143. Gilead Sciences Corporate Information, Location and Competitors
Table 144. Gilead Sciences Liver Diseases Treatment Major Business
Table 145. Gilead Sciences Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 146. Gilead Sciences SWOT Analysis
Table 147. Gilead Sciences Liver Diseases Treatment Product and Solutions
Table 148. Gilead Sciences Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 149. Raptor Pharmaceuticals Corporate Information, Location and Competitors
Table 150. Raptor Pharmaceuticals Liver Diseases Treatment Major Business
Table 151. Raptor Pharmaceuticals Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 152. Raptor Pharmaceuticals SWOT Analysis
Table 153. Raptor Pharmaceuticals Liver Diseases Treatment Product and Solutions
Table 154. Raptor Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 155. Achillion Pharmaceuticals Corporate Information, Location and Competitors
Table 156. Achillion Pharmaceuticals Liver Diseases Treatment Major Business
Table 157. Achillion Pharmaceuticals Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 158. Achillion Pharmaceuticals SWOT Analysis
Table 159. Achillion Pharmaceuticals Liver Diseases Treatment Product and Solutions
Table 160. Achillion Pharmaceuticals Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 161. ProMetic Life Sciences Corporate Information, Location and Competitors
Table 162. ProMetic Life Sciences Liver Diseases Treatment Major Business
Table 163. ProMetic Life Sciences Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 164. ProMetic Life Sciences SWOT Analysis
Table 165. ProMetic Life Sciences Liver Diseases Treatment Product and Solutions
Table 166. ProMetic Life Sciences Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 167. Cura Healthcare Corporate Information, Location and Competitors
Table 168. Cura Healthcare Liver Diseases Treatment Major Business
Table 169. Cura Healthcare Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 170. Cura Healthcare SWOT Analysis
Table 171. Cura Healthcare Liver Diseases Treatment Product and Solutions
Table 172. Cura Healthcare Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 173. Shenzhen Kangtai Biological Products Corporate Information, Location and Competitors
Table 174. Shenzhen Kangtai Biological Products Liver Diseases Treatment Major Business
Table 175. Shenzhen Kangtai Biological Products Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 176. Shenzhen Kangtai Biological Products SWOT Analysis
Table 177. Shenzhen Kangtai Biological Products Liver Diseases Treatment Product and Solutions
Table 178. Shenzhen Kangtai Biological Products Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 179. Angion Biomedica Corporate Information, Location and Competitors
Table 180. Angion Biomedica Liver Diseases Treatment Major Business
Table 181. Angion Biomedica Liver Diseases Treatment Total Revenue (USD Million) (2017-2018)
Table 182. Angion Biomedica SWOT Analysis
Table 183. Angion Biomedica Liver Diseases Treatment Product and Solutions
Table 184. Angion Biomedica Liver Diseases Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 185. Global Liver Diseases Treatment Revenue (Million USD) by Players (2015-2020)
Table 186. Global Liver Diseases Treatment Revenue Share by Players (2015-2020)
Table 187. Global Liver Diseases Treatment Revenue (Million USD) by Regions (2015-2020)
Table 188. Global Liver Diseases Treatment Revenue Market Share by Regions (2015-2020)
Table 189. North America Liver Diseases Treatment Revenue by Countries (2015-2020)
Table 190. North America Liver Diseases Treatment Revenue Market Share by Countries (2015-2020)
Table 191. Europe Liver Diseases Treatment Revenue (Million USD) by Countries (2015-2020)
Table 192. Asia-Pacific Liver Diseases Treatment Revenue (Million USD) by Countries (2015-2020)
Table 193. South America Liver Diseases Treatment Revenue by Countries (2015-2020)
Table 194. South America Liver Diseases Treatment Revenue Market Share by Countries (2015-2020)
Table 195. Middle East and Africa Liver Diseases Treatment Revenue (Million USD) by Countries (2015-2020)
Table 196. Middle East and Africa Liver Diseases Treatment Revenue Market Share by Countries (2015-2020)
Table 197. Global Liver Diseases Treatment Revenue (Million USD) by Type (2015-2020)
Table 198. Global Liver Diseases Treatment Revenue Share by Type (2015-2020)
Table 199. Global Liver Diseases Treatment Revenue Forecast by Type (2021-2025)
Table 200. Global Liver Diseases Treatment Revenue by Application (2015-2020)
Table 201. Global Liver Diseases Treatment Revenue Share by Application (2015-2020)
Table 202. Global Liver Diseases Treatment Revenue Forecast by Application (2021-2025)
Table 203. Global Liver Diseases Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Liver Diseases Treatment Picture
Figure 2. Global Liver Diseases Treatment Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Drugs Picture
Figure 4. Targeted Therapy Picture
Figure 5. Anti-Viral Drugs Picture
Figure 6. Immunoglobulins Picture
Figure 7. Corticosteroids Picture
Figure 8. Vaccines Picture
Figure 9. Anti-Rejection Drugs/Immunosuppressant Picture
Figure 10. Liver Diseases Treatment Revenue Market Share by Application in 2019
Figure 11. Cancer Picture
Figure 12. Hepatitis Picture
Figure 13. Cirrhosis Picture
Figure 14. Other Picture
Figure 15. Global Liver Diseases Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Liver Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Liver Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Liver Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Liver Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Liver Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Liver Diseases Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Liver Diseases Treatment Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Liver Diseases Treatment Revenue Market Share in 2019
Figure 24. Global Top 10 Players Liver Diseases Treatment Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Liver Diseases Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Liver Diseases Treatment Revenue Market Share by Regions (2015-2020)
Figure 28. Global Liver Diseases Treatment Revenue Market Share by Regions in 2018
Figure 29. North America Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Europe Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 32. South America Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 34. North America Liver Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. North America Liver Diseases Treatment Revenue Market Share by Countries in 2019
Figure 36. USA Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Canada Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Europe Liver Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Liver Diseases Treatment Revenue Market Share by Countries in 2019
Figure 41. Germany Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 42. UK Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 43. France Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Russia Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Italy Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Liver Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Liver Diseases Treatment Revenue Market Share by Countries in 2019
Figure 48. China Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Japan Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Korea Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 51. India Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 53. South America Liver Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. South America Liver Diseases Treatment Revenue Market Share by Countries in 2019
Figure 55. Brazil Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Liver Diseases Treatment Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Liver Diseases Treatment Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 60. UAE Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Liver Diseases Treatment Revenue and Growth Rate (2015-2020)
Figure 63. Global Liver Diseases Treatment Revenue Share by Type (2015-2020)
Figure 64. Global Liver Diseases Treatment Revenue Share by Type in 2019
Figure 65. Global Liver Diseases Treatment Market Share Forecast by Type (2021-2025)
Figure 66. Global Chemotherapy Drugs Revenue Growth Rate (2015-2020)
Figure 67. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 68. Global Anti-Viral Drugs Revenue Growth Rate (2015-2020)
Figure 69. Global Immunoglobulins Revenue Growth Rate (2015-2020)
Figure 70. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 71. Global Vaccines Revenue Growth Rate (2015-2020)
Figure 72. Global Anti-Rejection Drugs/Immunosuppressant Revenue Growth Rate (2015-2020)
Figure 73. Global Liver Diseases Treatment Revenue Share by Application (2015-2020)
Figure 74. Global Liver Diseases Treatment Revenue Share by Application in 2019
Figure 75. Global Liver Diseases Treatment Market Share Forecast by Application (2021-2025)
Figure 76. Global Cancer Revenue Growth Rate (2015-2020)
Figure 77. Global Hepatitis Revenue Growth Rate (2015-2020)
Figure 78. Global Cirrhosis Revenue Growth Rate (2015-2020)
Figure 79. Global Other Revenue Growth Rate (2015-2020)
Figure 80. Global Liver Diseases Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Liver Diseases Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Liver Diseases Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Liver Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 84. Europe Liver Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Liver Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 86. South America Liver Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Liver Diseases Treatment Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
乳がん治療薬の世界市場 2020年 Market Overview The global Breast Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast Cancer T…- 脳卒中治療薬の世界市場 2020年 Market Overview The global Stroke Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Stroke Treatment Drugs…
- 瘢痕治療薬の世界市場 2020年 Market Overview The Scar Treatment Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- ポルフィリン症薬の世界市場 2020年 Market Overview The global Porphyrias Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Porphyrias Drugs market repo…
- 肝臓健康サプリメントの世界市場 2020年 Market Overview The global Liver Health Supplements market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Liver Health Supplem…